Vitreous fluid chemicals in eye diseases
Part of Eyes & vision clinical trials.
This study looks at the chemicals in the fluid inside your eye (vitreous) using a special scan. It aims to find patterns that might help doctors understand certain eye diseases better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have one of these eye conditions: idiopathic macular hole, diabetic retinopathy, retinal detachment, idiopathic macular membrane, or retinal vein occlusion
- Your doctor has recommended a vitrectomy surgery to treat your eye condition
- You have not had a vitrectomy in the past
- You do not have another active eye disease like an infection or inflammation
- You do not have a serious overall health problem like uncontrolled high blood pressure or diabetes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a robotic system to assist eye surgery for certain retina and vitreous conditions, such as bleeding in the eye or a wrinkle on the macula. It aims to see if the robot can safely help improve vision.
This study looks at how well surgery called vitrectomy works for people with severe nonproliferative diabetic retinopathy (NPDR), a condition where high blood sugar damages the retina. The trial aims to see if this surgery can improve vision and outcomes.
This study collects retina fluid samples from people getting treatment for a vitreoretinal disease. It aims to find better ways to understand and manage these conditions.
This study looks at imaging and blood-based markers to better understand retinal detachment. It aims to find ways to predict how well the retina might reattach after surgery.
This study is building a detailed database of images and information from people with various eye diseases, especially those involving inflammation or swelling. Researchers will use advanced cameras and tests to better understand these conditions and potentially improve treatments.
This Phase 2 trial tests an injection of topotecan into the eye after surgery for retinal detachment that keeps coming back due to scar tissue (proliferative vitreoretinopathy). It may help improve how the retina heals after difficult, repeat operations when vision is usually very guarded.
Hear when a new Vitreoretinal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.